t turns out that there have been many trials of the type Temple mentioned. In 2001, the Danish epidemiologist As- bjorn Hróbjartsson, of Copenhagen's Nordic Cochrane Center, along with his colleague Peter Gotzsche, published a systematic review of a hundred and four- teen clinical trials that compared patients who receiv